EVOLENT HEALTH INC CLASS A overview

Evolent Announces Fourth Quarter and Full Year 2024 Results PR Newswire WASHINGTON, Feb. 20, 2025 Revenue of $646.5 million for the three months ended December 31, 2024 and $2,554.7 million for the year ended December 31, 2024 , representing 16.3% and 30.1% growth over 2023, respectively. Net loss attributable to common shareholders of Evolent Health, Inc. of $30.6 million for three months ended December 31, 2024 and $93.5 million for the year ended December 31, 2024 , resulting in a net loss...

Evolent Health Announces Changes to Board of Directors PR Newswire WASHINGTON, Feb. 4, 2025 Richard " Rick " Jelinek to Be Named Chair of the Board at 2025 Annual Meeting Company Continues Board Refreshment Efforts with Brendan Springstubb ' s Appointment as New Independent Director WASHINGTON , Feb. 4, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent"), a company focused on achieving better health outcomes for people with complex conditions, today announced changes to its Board...

Evolent To Release Fourth Quarter 2024 Financial Results on Thursday, February 20, 2025 PR Newswire WASHINGTON, Jan. 27, 2025 Company to Participate in Upcoming Conferences WASHINGTON , Jan. 27, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced it will release its fourth quarter 2024 financial results on Thursday, February 20, 2025, after market close, with a conference call to follow...

Evolent announces Dr. Von Nguyen as incoming Chief Medical Officer, effective January 1 PR Newswire WASHINGTON, Dec. 18, 2024 Longtime CMO Dr. Andrew Hertler to serve as senior advisor and CMO emeritus. WASHINGTON , Dec. 18, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, announced the appointment of Dr. Von Nguyen as Chief Medical Officer, effective January 1, 2025 . Dr. Nguyen joined Evolent as...

Evolent Announces Third Quarter 2024 Results PR Newswire WASHINGTON, Nov. 7, 2024 Revenue of $621.4 million , an increase of $110.4 million or 21.6% , from the three months ended September 30, 2023 . Net loss attributable to common shareholders of Evolent Health, Inc. of $(31.2) million and a net loss margin of (5.0)% . Adjusted EBITDA of $31.8 million resulting in an Adjusted EBITDA margin of 5.1% . Revises outlook for Adjusted EBITDA for 2024. Reiterates average annual long-term revenue and...

Evolent To Release Third Quarter 2024 Financial Results on Thursday, November 7, 2024 PR Newswire WASHINGTON, Oct. 11, 2024 Company to Participate in Upcoming Conferences WASHINGTON , Oct. 11, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced it will release its third quarter 2024 financial results on Thursday,...

Evolent Announces Second Quarter 2024 Results PR Newswire WASHINGTON, Aug. 8, 2024 Revenue of $647.1 million , an increase of $178.0 million or 37.9% , from the three months ended June 30, 2023 . Net loss attributable to common shareholders of Evolent Health, Inc. of $(6.4) million and a net loss margin of (1.0)% . Adjusted EBITDA of $52.0 million resulting in an Adjusted EBITDA margin of 8.0% . Narrows revenue outlook for full year 2024 and provides updated 2024 Adjusted EBITDA guidance....

Evolent To Release Second Quarter 2024 Financial Results on Thursday, August 8, 2024 PR Newswire WASHINGTON, July 11, 2024 Company to Participate in Upcoming Conferences WASHINGTON , July 11, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced it will release its second quarter 2024 financial results on Thursday,...